Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Heart Disease
Trial Information
Heart Disease Clinical Research Study
The latest in heart disease research
We all know that high cholesterol can increase your risk of
heart attacks or strokes, and that statin medications can help
lower high cholesterol. Doctors and scientists know now that
inflammation in the body can also increase heart disease risk. A
naturally occurring enzyme, called Lp-PLA2, is an inflammatory
marker that may increase the risk of heart attacks and strokes if
elevated.
If you know you are at risk for heart disease, you may qualify
for a clinical research study now underway at Diablo Clinical
Research focusing on the inflammatory enzyme Lp-PLA2. This study
involves an investigational medication in combination with an
approved cholesterol medication to determine its effects on both
Lp-PLA2 and cholesterol levels, and to determine if it can reduce
future heart disease risk.
You may qualify if you have high cholesterol and are at risk
because of heart disease. Even if you’re already taking cholesterol
medication, you still may qualify.
You may qualify for this study if you have:
- High cholesterol and
- Are at high risk because of heart disease:
- coronary heart disease
- coronary angiography
- prior coronary artery bypass surgery
- prior heart attack
- carotid artery disease
- peripheral arterial disease
- diabetes
- or other risk factors for heart disease indicating high risk
for future coronary events
All participants will receive at no charge all
study-related:
- Study medication including approved medication to lower
cholesterol
- Diet and exercise advice
- Medical care
Study stipend is also included for enrolled participants.
For additional information, please visit:
www.diabloclinical.com
Diablo Clinical Research
2255 Ygnacio Valley Road, Suite M
Walnut Creek, CA 94598
Phone: 925-930-7267
EMail: apaulazzo@diabloclinical.com
View Google Map
Research Center Information: Diablo Clinical Research
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
